[EN] SPIRO ISOXAZOLINE COMPOUNDS AS SSTR5 ANTAGONISTS<br/>[FR] COMPOSÉS SPIROISOXAZOLINES EN TANT QU'ANTAGONISTES SSTR5
申请人:MERCK SHARP & DOHME
公开号:WO2011146324A1
公开(公告)日:2011-11-24
Substituted spirocyclic amines of structural formula (I) are selective antagonists of the somatostatin subtype receptor 5 (SSTR5) and are useful for the treatment, control or prevention of disorders responsive to antagonism of SSTR5, such as Type 2 diabetes, insulin resistance, lipid disorders, obesity, atherosclerosis, Metabolic Syndrome, depression, and anxiety.
结构式(I)的螺环胺是生长抑素亚型受体5(SSTR5)的选择性拮抗剂,对于对抗SSTR5有响应的疾病的治疗、控制或预防是有用的,如2型糖尿病、胰岛素抵抗、脂质紊乱、肥胖、动脉粥样硬化、代谢综合征、抑郁症和焦虑症。